A cyclin-dependent kinase inhibitor, dinaciclib, impairs homologous recombination and sensitizes multiple myeloma cells to PARP inhibition
-
- Shmookler Reis
- 作成者
収録刊行物
-
- Mol Cancer Ther
-
Mol Cancer Ther 2016 (15), 241-,